Literature DB >> 20299747

Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.

Tamiko Nagao1, Tomoki Yamashita, Ariko Miyake, Tsuneo Uchiyama, Masako Nomaguchi, Akio Adachi.   

Abstract

We examined a series of site-directed point mutants of human immunodeficiency virus type 1 (HIV-1) Vif for their interaction with cellular anti-viral factors APOBEC3G/APOBEC3F. Mutant viruses that display growth-defect in H9 cells did not counteract effectively APOBEC3G and/or APOBEC3F without exception, as monitored by single-cycle infectivity assays. While growth-defective mutants of Vif C-terminal region were unable to suppress APOBEC3G/APOBEC3F, some N-terminal region mutants did neutralize one of APOBEC3G/APOBEC3F. These data have suggested that members of APOBEC3 family other than APOBEC3G/APOBEC3F are not important for anti-HIV-1 activity. Furthermore, APOPEC3G/APOBEC3F were found to differently associate with Vif in virions as analyzed by equilibrium density centrifugation. Taken together, these results indicated that interaction of HIV-1 Vif and APOBEC3G is distinct from that between Vif and APOBEC3F.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299747     DOI: 10.2152/jmi.57.89

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  5 in total

1.  APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.

Authors:  John F Krisko; Nurjahan Begum; Caroline E Baker; John L Foster; J Victor Garcia
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Authors:  John S Albin; William L Brown; Reuben S Harris
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

Review 3.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

4.  Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.

Authors:  Claudia Alteri; Matteo Surdo; Maria Concetta Bellocchi; Patrizia Saccomandi; Fabio Continenza; Daniele Armenia; Lucia Parrotta; Luca Carioti; Giosuè Costa; Slim Fourati; Fabiola Di Santo; Rossana Scutari; Silvia Barbaliscia; Valentina Fedele; Stefania Carta; Emanuela Balestra; Stefano Alcaro; Anne Genevieve Marcelin; Vincent Calvez; Francesca Ceccherini-Silberstein; Anna Artese; Carlo Federico Perno; Valentina Svicher
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

5.  HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.

Authors:  Sean L Evans; Arne Schön; Qimeng Gao; Xue Han; Xiaohong Zhou; Ernesto Freire; Xiao-Fang Yu
Journal:  Retrovirology       Date:  2014-01-14       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.